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Objective: To determine costs related to living with
rheumatoid arthritis (RA), and to identify the association
between health status—as measured by the Health Status
Questionnaire short form-36 (SF-36) and the disease
specific index Health Assessment Questionnaire (HAQ)—
and the social impact of RA.
Methods: A prospective cohort study was carried out on
81 patients with RA who completed four consecutive three
month cost diaries. The SF-36, HAQ, and social impact at
baseline and one year follow up were also assessed.
Results: Women reported worse SF-36 physical function
and HAQ scores than men and received more assistance
from family and friends. Women spent more on
non-prescription medication and devices to assist them
than men. Older patients had higher expenditure on visits
to health professionals, whereas younger patients spent
more on prescription medication and tests. Pension status
and membership of private health insurance schemes were
important determinants in these differences in expenditure.
Conclusion: Costs increased with duration of disease,
those with private health insurance had greater out of
pocket costs (excluding membership fees), and those with
pension support had fewer costs. Women were more
affected by RA than men in health status, social impact,
and out of pocket costs.
Rheumatoid arthritis (RA) is a disabling disease with sig-nificant costs to the health system and the patient.1–4 Inthis study the costs to the patient, rather than to the
healthcare system, were analysed together with measurement
of the health status and social effect of RA on the patient. This
paper reports on a subset of a large ongoing longitudinal study
on the costs and self reported health status of people with RA
in Australia.
The purpose of the analysis was to ascertain the partici-
pants’ “out of pocket” costs from RA and to explore whether
demographic details, health status scores, or perception of
social effect were determinants of out of pocket costs.
METHODS
Participants were referred to the study by rheumatologists at
St Vincent’s Clinic, Sydney, Australia. Approval for the study
was granted by the relevant institutional ethics committee.
Both public (those who were only covered by the government
funded health system) and private patients (those who
subscribed to private health insurance) were included in this
analysis. Patients undergoing joint replacement in this period
were excluded from the analyses reported here.
The short form-36 Health Status Questionnaire (SF-36)5
and Health Assessment Questionnaire (HAQ)6 were com-
pleted at entry into the study and at the end of one year. No
significant differences were found between baseline and one
year scores, so the questionnaires completed at one year were
used for further analysis.
In baseline questionnaires, participants were asked:
+”Has having arthritis affected your family or other close
relationships?”
+”Do you have family, friends, or relatives who provide you
with assistance?”
+”Have you had to change your living arrangements
because of your arthritis?” Respondents who replied yes to
these questions were asked to provide details.
The patients’ out of pocket costs were collected prospec-
tively through four cost diaries which each covered three
months and which were based on a previously validated Aus-
tralian cost of illness study.7 To confirm that diaries were a
valid means of collecting these data, in the initial phases of the
study home visits were made to a random sample of respond-
ents to compare their diary entries with actual receipts.
Disease related expenditure reported by the participants
included alterations to house, use of private and community
services, special equipment for their assistance (including
shoes and clothing), stay in hospital (related to arthritis but
not including joint replacement), medications (prescription
and non-prescription), visits to health professionals, and
medical tests. Respondents were instructed to record all visits
to health professionals and all purchased medications
whether they were charged or paid a reduced rate with a pen-
sioner concession—that is, they were covered by federal
government funded Medicare or “safety net”. Under this
safety net, patients pay about $A3 for each prescription for
items listed on the Pharmaceutical Benefits Scheme, until
they reach a certain level of out of pocket expenditure
(currently $A171.60) after which the health system covers the
entire cost of medication. Those not covered by the safety net
scheme pay about $AU20 until they reach a higher level of out
of pocket expenditure (currently $A631.20), after which they
pay $A3 for each prescription, the rate paid by patients with a
pensioner’s concession. Costs reported in the diaries were not
inflated to current values; therefore, results reported here are
1994 prices.
The distribution of total expenditure for one year was
significantly skewed to the left. There were two outliers
because one participant purchased a new car and another
made house alterations. Both of these major expenses were
attributable to RA, so remained in the analysis. The
non-parametric Mann-Whitney U test was used to analyse all
costs, and total expenditure was log transformed for
correlation and regression analysis.
Univariate analyses were conducted with log transformed
total expenditure to identify variables that were significantly
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associated. Regression analyses were undertaken to deter-
mine the association between demographic, socioeconomic,
and health status scores with total expenditure.
Seventeen independent variables were correlated with log
transformed total expenditure. These were age (in years), sex,
number of self reported comorbidities, pension status, years
with RA, eight SF-36 scores, HAQ score at one year, and social
impact questions, whether RA affected their relationships
with other people, if they received assistance from family and
friends, and if RA caused them to change their living arrange-
ments. Backward regression analyses were run using signifi-
cant univariate variables with total expenditure (log trans-
formed) as the dependent variable.
RESULTS
Although the study involved considerable commitment from
participants, 81 people (70%) provided one full year of data for
analysis. There were no differences in age, sex, duration of
disease, self reported comorbidities, or baseline HAQ score
between complete and partial responders.
Table 1 shows the characteristics of these participants.
Eighty per cent of respondents were women and the average
age was 58 with amean disease duration of 16 years. Although
not shown in table 1, women had had RA for a significantly
longer mean period (17 years) than men (nine years)
(p=0.004).
Health status questionnaires
Figure 1 shows the SF-36 scores of study participants and
those of the Australian general population.8 Similarly, figure 2
shows HAQ scores of study participants and the general
population in the northern Sydney area.9 Men reported
significantly better SF-36 physical function and overall HAQ
than women, but for both health status assessments patients
with RA were well below their age related peers.
Social aspects
Fifty three (65%) participants reported that RA affected their
relationships, with younger participants more likely to report
an effect than those aged 65 and older (p=0.021). Reduced
opportunity for social interaction (n=24) was the most com-
monly reported effect followed by reduced opportunity for
sport or outdoor activity (n=13). Of the thirteen respondents
who indicated that their role as helper or carer for the family
was affected, 12 were women.
Forty six (57%) participants reported receiving assistance
from family, friends, or relatives. Women were more likely to
report receiving assistance than men (65% and 25% respec-
tively, p=0.008). Domestic indoor duties (70% of the 46
people) and shopping (41%) were the main areas, followed by
carrying heavy items (20%), domestic outdoor (17%), driving
and transport (15%), opening jars (15%), and personal
hygiene (11%).
Table 1 Description of study participants and results of analyses
Mean SD Range
Number 81
% Female 80
Age (years) 58.2 11.22 32–77
Duration of disease 15.6 9.86 6 months–50
years
% Reporting other medical condition 48
% Receiving pension 31
% With private health insurance 77
Health status:
Physical function 47.13 27.83
Role physical 38.29 41.57
Bodily pain 50.43 22.96
General health 49.92 22.93
Vitality 49.29 22.25
Social function 71.23 26.57
Role emotional 63.82 45.16
Mental health 73.85 17.14
HAQ 1.28 0.73
Total expenditure ($) Men Women Significance
Mean (SD) 765.60
(1143.49)
1697.51
(2890.18)
Median 366.92 759.55 p=0.013
Minimum 49.62 49.80
Maximum 4462.19 20527.65
Total expenditure ($) <65 years >65 years Significance
Mean (SD) 1638.26
(2886.89)
1263.76
(2158.45)
Median 797.75 362.32 p=0.029
Minimum 49.62 49.80
Maximum 20527.65 9978.52
Regression analysis* R2=0.468
Variable β eβ Significance
SF-36 general health −0.431 0.650 0.000
Sex (0=male, 1=female) 0.197 1.218 0.038
Pension (1=yes, 2=no) 0.412 1.510 0.000
Private health insurance (1=yes, 2=no) −0.281 0.755 0.005
Receive assistance from family/friends (1=yes,
2=no) −0.177 0.838 0.073
*Other variables entered into the regression model were HAQ score, years with RA, and effect on
relationships.
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Forty per cent of respondents reported having to change
their living arrangements because of arthritis, including
undertaking general household alterations (31%), moving
house (28%), and changing daily routine (13%).
Out of pocket costs
All patients had out of pocket expenditure related to RA,
spending on average $A1513 (SD $A2658) annually. The
maximum yearly out of pocket expenditure on RA related
health care was $A20 527, and the minimum expenditure was
$A49. Women spent significantly more than men (median
$A760 v $A367) and the younger group (<65 years) spent sig-
nificantly more (median $A798 v $A362) than the older group
(table 1).
All participants reported expenditure on prescription medi-
cation in the data collection period. Seventy seven per cent of
women also reported expenditure on non-prescription medi-
cation whereas only 37.5% of men reported this (χ2=9.35
p=0.002). Similarly, 63.1% of women reported expenditure on
devices for assistance compared with only 18.7% of men.
Younger (<65 years) respondents spent significantly more
on prescription medication and tests than older respondents.
Older respondents spent significantly more on professional
visits, with 44.4% incurring expenses, whereas 81.5% of the
younger group reported some expense from professional
visits.
Interrelationship between health status, social aspects,
and out of pocket expenditures
Several variables were significantly correlated with the log
transformed total out of pocket expenditure, including sex
(p=0.015), which indicated that women spent significantly
more, and years with RA (p=0.021), which showed that out of
pocket costs increased as the disease progressed. Pension sta-
tus andmembership of private health insurance schemes were
also significantly correlated with expenditure (p=0.010 and
p=0.005), with pensioners spending less and members of pri-
vate health insurance schemes more out of their own pockets
(not including the membership payments, which would
increase this difference). Those who reported that RA had an
effect on their family and friendships spent significantly more
(p=0.002), as did those who reported receiving assistance
from family and friends (p=0.020).
The SF-36 general health (p=0.002) and HAQ (p=0.038)
were significantly associated with total expenditure, showing
that as general health declined, expenditure increased.
When these significant univariate variables were entered
into backward regression, female sex, pension, private health
insurance, SF-36 general health, and receiving assistance from
family and friends were identified as significant independent
predictors of total expenditure (log transformed). This model
explained 46.8% of the variance (table 1).
DISCUSSION
Although there is a wealth of research on various aspects of
the impact of living with RA both internationally2 10–12 and in
Australia,1 until now there has been no Australian study com-
bining health status, social impact, and out of pocket expendi-
ture for people living with RA.
Our group has undertaken a similar study of patients with
osteoarthritis (OA), finding that some of those with mild dis-
ease had no out of pocket costs in the year of data collection.13
However, whereas the patients with OA tended to have better
health status (using the SF-36) than the patients with RA the
only significantly different score was general health. Poorer
SF-36 general health scores were associated with increased
out of pocket costs for the RA group but not the OA group. As
well as these differences between OA and RA, a study of indi-
rect and non-medical expenses showed that people with
arthritis had expenditure nearly 2.5 times that of non-
arthritic people, averaging $US889.52 and $US334.88 respec-
tively, in 1992.14
Women reported worse health status, greater social impact,
and had greater out of pocket costs than men in our study
reported here. This could be partly attributed to the greater
duration of disease of the women in the study population. It
may also be explained in part by the sex differences in report-
ing and coping with illness. Van den Ende et al found in a
comparison of objective and subjective reporting of functional
Figure 1 SF-36 scores of patients with RA and the Australian population (aged 55–64). The SF-36 is on a 0–100 scale; a higher score
indicates better health.
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Figure 2 HAQ scores of patients with RA and an age related
population (65–74 years); sample from Northern Sydney Area
Health Service. HAQ score minimum=0, maximum=3; a higher score
indicates greater disability.
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status that male patients with RA overestimated their
functional ability considerably more than female patients.15
This, coupled with the societal construct that women carry a
greater load of domestic duties and acknowledge when they
are helped, may explain some of the discrepancies in health
status and social impact of RA between the sexes. The
Australian Bureau of Statistics reported that women, even
when working similar hours in paid work, spent more time on
domestic duties than their male partners.16 However, the
difference in cost is not accounted for by this. Therefore it
could be postulated that women purchase more pain relieving
medication because they acknowledge their functional dis-
ability and want to improve it, and that they purchase more
devices to assist them in their activities of daily living.
The other striking finding of this study is the impact of pay-
ment systems in Australia. Although out of pocket costs
increased with duration of disease, pension status was signifi-
cantly correlated with fewer costs suggesting that either a
greater proportion of their purchases are covered by the
government or that they are able to purchase less. Conversely,
younger participants in the study had greater private health
insurance membership, which was associated with greater out
of pocket costs, even without the inclusion of membership
fees.
CONCLUSION
People with RA report worse health status than their age
related peers. Women are affected more by RA than men,
resulting in the self reporting of poorer health status, greater
social impact, and higher out of pocket costs. Those who are
younger and with private health insurance are carrying a
greater personal financial burden as a result of RA than their
older counterparts who are covered by pensions.
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